Alnylam Pharmaceuticals, Inc. (ALNY)

351.99 -7.28 (-2.03%) USD  |  NASDAQ  |  Jan 20, 12:40
More

Alnylam Pharmaceuticals Changes in Working Capital (Quarterly)

Changes in Working Capital (Quarterly) Chart

View Changes in Working Capital (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Changes in Working Capital (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Changes in Working Capital (Quarterly) Range, Past 5 Years

View Changes in Working Capital (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Changes in Working Capital (Quarterly) Benchmarks

View Changes in Working Capital (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Biogen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade